How does autoimmune thyroiditis (Hashimoto's thyroiditis) present differently from viral (subacute De Quervain) thyroiditis?

Clinical Differentiation: Autoimmune Thyroiditis vs. Viral Thyroiditis

Autoimmune thyroiditis (Hashimoto's) presents as a chronic, painless condition with gradual onset of hypothyroidism and positive thyroid antibodies, while viral thyroiditis (De Quervain's) presents acutely with severe thyroid pain, fever, and markedly elevated inflammatory markers in a self-limited course.

Key Distinguishing Features

Pain and Tenderness

• Viral thyroiditis: Moderate-to-severe anterior neck pain radiating to ears, jaw, or throat is the hallmark feature, with a firm, exquisitely tender thyroid on palpation 1
• Autoimmune thyroiditis: Typically painless, though rare painful exacerbations can occur 2
• The presence of significant thyroid pain strongly suggests viral rather than autoimmune etiology 3

Onset and Temporal Pattern

• Viral thyroiditis: Acute onset following viral illness, with pain that may begin focally and spread throughout the gland over several weeks 1
• Autoimmune thyroiditis: Gradual, insidious onset over months to years 4
• Viral thyroiditis is self-limited, typically resolving completely within months, while autoimmune thyroiditis is relentless and progressive 4, 5

Systemic Symptoms

• Viral thyroiditis: Low-grade fever, malaise, severe fatigue, and myalgias are prominent 1, 4
• Autoimmune thyroiditis: Presents with classic hypothyroid symptoms (cold intolerance, dry skin, constipation, fatigue) or may be asymptomatic in the euthyroid phase 6

Laboratory Findings

Inflammatory Markers:

• Viral thyroiditis: Markedly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), with mild anemia common 1, 5
• Autoimmune thyroiditis: Normal ESR and CRP 5

Thyroid Antibodies:

• Viral thyroiditis: Thyroid autoantibodies (anti-TPO, anti-thyroglobulin) are absent 7, 1
• Autoimmune thyroiditis: Anti-thyroid peroxidase antibodies (TPOAb) positive in approximately 75% of patients 8, 6
• The presence of elevated TPOAb essentially rules out viral thyroiditis 5

Radioactive Iodine Uptake (RAIU)

• Both conditions: RAIU is universally low during the thyrotoxic phase 1, 5
• This occurs due to thyroid hormone leakage from damaged follicles with TSH suppression in both conditions 1
• RAIU cannot distinguish between these entities during the hyperthyroid phase 5

Thyroid Ultrasound

• Viral thyroiditis: Diffuse heterogeneity with decreased or normal color-flow Doppler (not the enhanced flow seen in Graves' disease) 1
• Autoimmune thyroiditis: May show diffuse hypoechogenicity with heterogeneous echotexture 9

Clinical Course and Phases

Viral Thyroiditis:

• Triphasic pattern: initial thyrotoxicosis (weeks), followed by hypothyroidism (weeks to months), then recovery to normal thyroid function in most patients 10, 4
• The hyperthyroid phase is self-limited, typically lasting several weeks 11
• Complete recovery occurs in the majority of cases 4, 5

Autoimmune Thyroiditis:

• Most commonly presents in the euthyroid (compensated) phase (60% of screened patients) 6
• Progressive disease with 4.3% annual risk of developing overt hypothyroidism in TPOAb-positive patients 6
• Permanent hypothyroidism requiring lifelong thyroid hormone replacement is the typical outcome 10, 4
• A transient hyperthyroid phase ("Hashitoxicosis") occurs in only 5% of cases and lasts 1-6 months 7

Physical Examination

Goiter Characteristics:

• Viral thyroiditis: Firm, painful, tender thyroid gland 1, 3
• Autoimmune thyroiditis: Diffuse, firm, non-tender goiter present in up to 60% of patients 6

Associated Findings:

• Autoimmune thyroiditis: Delayed ankle-reflex relaxation time correlates with hypothyroidism severity 6
• Autoimmune thyroiditis: Frequently associated with other autoimmune conditions (type 1 diabetes, celiac disease, pernicious anemia, rheumatoid arthritis) 6

Treatment Implications

Viral Thyroiditis:

• Beta-blockers for symptomatic thyrotoxicosis 1, 10
• NSAIDs for mild-to-moderate pain 1, 10
• Corticosteroids (prednisone 40 mg daily for 2-4 weeks, then taper) for moderate-to-severe symptoms or failure to respond to NSAIDs 1
• No antithyroid drugs needed, as hyperthyroidism is due to hormone release, not overproduction 1, 11
• Temporary levothyroxine may be used during hypothyroid phase but should be withdrawn after 3-6 months to verify recovery 1

Autoimmune Thyroiditis:

• Lifelong levothyroxine therapy for overt hypothyroidism (TSH >10 mIU/L with low free T4) 10
• Monitoring without treatment for euthyroid phase with positive antibodies 6
• No benefit from levothyroxine in subclinical hypothyroidism (TSH 4.5-10 mIU/L) based on randomized trials 6

Critical Diagnostic Pitfall

While the clinical presentations are typically distinct, rare cases of Hashimoto's thyroiditis can present with painful thyroid exacerbation mimicking De Quervain's thyroiditis 2. In such cases, markedly elevated thyroid antibody titers combined with biochemical evidence of hypothyroidism confirm the diagnosis of autoimmune thyroiditis despite the atypical painful presentation 2.